Catalog

Osteoporosis, the most common bone disease, is associated with significant morbidity and mortality in older women and men. Fractures related to osteoporosis occur in both women and men, at a total of approximately 2 million fractures per year. Though osteoporosis has a significant impact on older Americans, it remains under-diagnosed. This educational program will focus on diagnostic guidelines, appropriate pharmacologic recommendations, and treatment monitoring. PAs who participate in this program will be better able to diagnose patients with osteoporosis and recognize the impact of the disease. These PAs will also be more prepared to assess the clinical safety and efficacy profiles of pharmacologic therapies and select appropriate agents for patients with osteoporosis. Additionally, PAs will be better prepared to monitor patients who receive treatment for osteoporosis, including in the assessment of treatment response.

This presentation explores the value of PAs in healthcare, examining key components that contribute to patient outcomes and employer benefits. Participants will analyze evidence supporting PA value, assess methods of measurement, and discuss limitations that may underestimate their impact. By understanding these factors, PAs will be better equipped to demonstrate their contributions effectively to employers, colleagues, and the healthcare system as a whole.

This presentation provides PAs with a comprehensive overview of healthcare reimbursement, including evolving payment models and value-based care. Participants will explore key Medicare billing policies, such as “incident to” and “shared visit” billing, as well as essential enrollment and credentialing requirements for payer reimbursement. By understanding these critical financial and regulatory aspects, PAs can optimize billing practices, maximize reimbursement, and enhance the financial sustainability of their clinical practice.

Osteoporosis, the most common bone disease, is associated with significant morbidity and mortality in older women and men. Fractures related to osteoporosis occur in both women and men, at a total of approximately 2 million fractures per year. Though osteoporosis has a significant impact on older Americans, it remains under-diagnosed. This educational program will focus on diagnostic guidelines, appropriate pharmacologic recommendations, and treatment monitoring. PAs who participate in this program will be better able to diagnose patients with osteoporosis and recognize the impact of the disease. These PAs will also be more prepared to assess the clinical safety and efficacy profiles of pharmacologic therapies and select appropriate agents for patients with osteoporosis. Additionally, PAs will be better prepared to monitor patients who receive treatment for osteoporosis, including in the assessment of treatment response.

Osteoporosis, the most common bone disease, is associated with significant morbidity and mortality in older women and men. Fractures related to osteoporosis occur in both women and men, at a total of approximately 2 million fractures per year. Though osteoporosis has a significant impact on older Americans, it remains under-diagnosed. This educational program will focus on diagnostic guidelines, appropriate pharmacologic recommendations, and treatment monitoring. PAs who participate in this program will be better able to diagnose patients with osteoporosis and recognize the impact of the disease. These PAs will also be more prepared to assess the clinical safety and efficacy profiles of pharmacologic therapies and select appropriate agents for patients with osteoporosis. Additionally, PAs will be better prepared to monitor patients who receive treatment for osteoporosis, including in the assessment of treatment response.

The 2025 Standards of Care in Diabetes includes all the American Diabetes Association’s (ADA) current clinical practice recommendations and is intended to provide clinicians, patients, researchers, payers, and others with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care. The recommendations are based on an extensive review of the clinical diabetes literature, supplemented with input from ADA staff and the medical community at large. The Standards of Care in Diabetes is updated annually, or more frequently online if new evidence or regulatory changes merit immediate incorporation and is published in Diabetes Care. Join us to hear first-hand updates to the 2025 Standards of Care guidelines.

Chimeric Antigen Receptor Therapy in Hematologic Malignancies | Understanding Pediatric Cervicofacial Non-Tuberculous Mycobacterial Infection

To boost early detection of cognitive decline, the American Academy of Physician Associates and the PA Foundation partnered with Cleveland Clinic to create a cognitive assessment toolkit for healthcare providers.

Featuring recorded sessions from the 2025 We Are Family (Medicine) conference, the Family Medicine on Demand 2025 course is designed for Physician Associates (PAs) and Nurse Practitioners (NPs) in family medicine, offering essential, evidence-based content to enhance clinical practice. This video-based CME activity offers up to 28.0 credits of AAPA Category 1 CME. Topics include the management of thyroid disorders, mental health conditions, anemia, and diabetes, as well as approaches for obesity treatment, congestive heart failure, and preoperative risk assessment. Learners will also explore critical aspects of LGBTQIA+ healthcare, celiac disease, and the interpretation of electrocardiograms. Additional sessions cover vaccinations, orthopedics, and more practical strategies for improving patient care in a wide range of primary care settings. The course is designed to be flexible and self-paced, with expert-led video content that empowers providers to stay current with best practices, enhance their clinical decision-making, and improve patient outcomes across diverse health conditions.

Healthcare providers who prescribe opioid analgesics have a responsibility to help ensure the safe and effective use of opioid analgesics. This educational initiative is intended for PAs involved in the care of patients with chronic pain, focuses on the safe and prescribing of opioid analgesics and meets the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).